The global Montelukast Sodium Tablet market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.

The main ingredient of montelukast sodium tablets is montelukast sodium, an oral leukotriene receptor antagonist

From a downstream perspective, Hospital accounted for % of 2024 revenue, surging to US$ million by 2031 (CAGR: % from 2025–2031).

Montelukast Sodium Tablet leading manufacturers including Shanghai Anbisheng Pharmaceutical Technology Co. Ltd, Jiangsu Vanguard Pharmaceutical Co.,Ltd., Lunan Better Pharmaceutical Co.,Ltd, Otsuka, Organon Pharma (UK) Limited, Taiwan Biotech Co., Ltd, Sandoz Private Limited, N.V. Organon, etc., dominate supply; the top five capture approximately % of global revenue, with Shanghai Anbisheng Pharmaceutical Technology Co. Ltd leading 2024 sales at US$ million.

Regional Outlook:

North America rose from US$ million in 2024 to a forecast US$ million by 2031 (CAGR %).

Asia‑Pacific will expand from US$ million to US$ million (CAGR  %), led by China (US$ million in 2024, % share rising to % by 2031), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).

Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2031 (CAGR %).

Report Includes:

This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Montelukast Sodium Tablet market, seamlessly integrating production and sales performance across the value chain. It analyzes historical sales volume and revenue sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.

By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.

Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.

Critical competitive intelligence profiles manufacturers—sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.

A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.

Market Segmentation

Scope of Montelukast Sodium Tablet Market Report

Report Metric	Details
Report Name	Montelukast Sodium Tablet Market
Segment by Type	Original Drug Generic Drug
Segment by Application	Hospital Pharmacy Others
Sales by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Shanghai Anbisheng Pharmaceutical Technology Co. Ltd, Jiangsu Vanguard Pharmaceutical Co.,Ltd., Lunan Better Pharmaceutical Co.,Ltd, Otsuka, Organon Pharma (UK) Limited, Taiwan Biotech Co., Ltd, Sandoz Private Limited, N.V. Organon
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Defines the Montelukast Sodium Tablet study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
Chapter 4: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
Chapter 6: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.
Chapter 7: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.
Chapter 8: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
Chapter 9: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
Chapter 10: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
Chapter 11: Profiles manufacturers in depth—details product specs, sales, revenue, margins; Top manufactures 2024 sales breakdowns by Product type, by Application, by sales region SWOT analysis, and recent strategic developments.
Chapter 12: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint, regional production and cost, regulatory and technology, plus downstream channels and distributor roles.
Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 15: Actionable conclusions and strategic recommendations.
Why This Report:
Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 12) and customers (Chapter5) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 12 and 13).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

FAQ for this report

Who are the main players in the Montelukast Sodium Tablet Market report?

Ans: The main players in the Montelukast Sodium Tablet Market are Shanghai Anbisheng Pharmaceutical Technology Co. Ltd, Jiangsu Vanguard Pharmaceutical Co.,Ltd., Lunan Better Pharmaceutical Co.,Ltd, Otsuka, Organon Pharma (UK) Limited, Taiwan Biotech Co., Ltd, Sandoz Private Limited, N.V. Organon

What are the Application segmentation covered in the Montelukast Sodium Tablet Market report?

Ans: The Applications covered in the Montelukast Sodium Tablet Market report are Hospital, Pharmacy, Others

What are the Type segmentation covered in the Montelukast Sodium Tablet Market report?

Ans: The Types covered in the Montelukast Sodium Tablet Market report are Original Drug, Generic Drug

1 Study Coverage

1.1 Introduction to Montelukast Sodium Tablet: Definition, Properties, and Key Attributes

1.2 Market Segmentation by Type

1.2.1 Global Montelukast Sodium Tablet Market Size by Type, 2020 VS 2024 VS 2031

1.2.2 Original Drug

1.2.3 Generic Drug

1.3 Market Segmentation by Application

1.3.1 Global Montelukast Sodium Tablet Market Size by Application, 2020 VS 2024 VS 2031

1.3.2 Hospital

1.3.3 Pharmacy

1.3.4 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Executive Summary

2.1 Global Montelukast Sodium Tablet Revenue Estimates and Forecasts 2020-2031

2.2 Global Montelukast Sodium Tablet Revenue by Region

2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031

2.2.2 Historical and Forecasted Revenue by Region (2020--2031)

2.2.3 Global Revenue Market Share by Region (2020-2031)

2.3 Global Montelukast Sodium Tablet Sales Estimates and Forecasts 2020-2031

2.4 Global Montelukast Sodium Tablet Sales by Region

2.4.1 Sales Comparison: 2020 VS 2024 VS 2031

2.4.2 Historical and Forecasted Sales by Region (2020-2031)

2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends

2.4.4 Global Sales Market Share by Region (2020-2031)

3 Competition by Manufacturers

3.1 Global Montelukast Sodium Tablet Sales by Manufacturers

3.1.1 Global Sales Volume by Manufacturers (2020-2025)

3.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)

3.2 Global Montelukast Sodium Tablet Manufacturer Revenue Rankings and Tiers

3.2.1 Global Revenue (Value) by Manufacturers (2020-2025)

3.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)

3.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)

3.3 Manufacturer Profitability Profiles and Pricing Strategies

3.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)

3.3.2 Manufacturer-Level Price Trends (2020-2025)

3.4 Key Manufacturers Manufacturing Base and Headquarters

3.5 Main Product Type Market Size by Manufacturers

3.5.1 Original Drug Market Size by Manufacturers

3.5.2 Generic Drug Market Size by Manufacturers

3.6 Global Montelukast Sodium Tablet Market Concentration and Dynamics

3.6.1 Global Market Concentration (CR5 and HHI)

3.6.2 Entrant/Exit Impact Analysis

3.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment

4 Global Product Segmentation Analysis

4.1 Global Montelukast Sodium Tablet Sales Performance by Type

4.1.1 Global Historical and Forecasted Sales by Type (2020-2031)

4.1.2 Global Sales Market Share by Type (2020-2031)

4.2 Global Montelukast Sodium Tablet Revenue Trends by Type

4.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)

4.2.2 Global Revenue Market Share by Type (2020-2031)

4.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)

4.4 Product Technology Differentiation

4.5 Subtype Dynamics: Growth Leaders, Profitability and Risk

4.5.1 High-Growth Niches and Adoption Drivers

4.5.2 Profitability Hotspots and Cost Drivers

4.5.3 Substitution Threats

5 Global Downstream Application Analysis

5.1 Global Montelukast Sodium Tablet Sales by Application

5.1.1 Global Historical and Forecasted Sales by Application (2020-2031)

5.1.2 Global Sales Market Share by Application (2020-2031)

5.1.3 High-Growth Application Identification

5.1.4 Emerging Application Case Studies

5.2 Global Montelukast Sodium Tablet Revenue by Application

5.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)

5.2.2 Revenue Market Share by Application (2020-2031)

5.3 Global Pricing Dynamics by Application (2020-2031)

5.4 Downstream Customer Analysis

5.4.1 Top Customers by Region

5.4.2 Top Customers by Application

6 North America

6.1 North America Sales Volume and Revenue (2020-2031)

6.2 North America Key Manufacturers Sales Revenue in 2024

6.3 North America Montelukast Sodium Tablet Sales and Revenue by Type (2020-2031)

6.4 North America Montelukast Sodium Tablet Sales and Revenue by Application (2020-2031)

6.5 North America Growth Accelerators and Market Barriers

6.6 North America Montelukast Sodium Tablet Market Size by Country

6.6.1 North America Revenue by Country

6.6.2 North America Sales Trends by Country

6.6.3 US

6.6.4 Canada

6.6.5 Mexico

7 Europe

7.1 Europe Sales Volume and Revenue (2020-2031)

7.2 Europe Key Manufacturers Sales Revenue in 2024

7.3 Europe Montelukast Sodium Tablet Sales and Revenue by Type (2020-2031)

7.4 Europe Montelukast Sodium Tablet Sales and Revenue by Application (2020-2031)

7.5 Europe Growth Accelerators and Market Barriers

7.6 Europe Montelukast Sodium Tablet Market Size by Country

7.6.1 Europe Revenue by Country

7.6.2 Europe Sales Trends by Country

7.6.3 Germany

7.6.4 France

7.6.5 U.K.

7.6.6 Italy

7.6.7 Russia

8 Asia-Pacific

8.1 Asia-Pacific Sales Volume and Revenue (2020-2031)

8.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024

8.3 Asia-Pacific Montelukast Sodium Tablet Sales and Revenue by Type (2020-2031)

8.4 Asia-Pacific Montelukast Sodium Tablet Sales and Revenue by Application (2020-2031)

8.5 Asia-Pacific Montelukast Sodium Tablet Market Size by Region

8.5.1 Asia-Pacific Revenue by Region

8.5.2 Asia-Pacific Sales Trends by Region

8.6 Asia-Pacific Growth Accelerators and Market Barriers

8.7 Southeast Asia

8.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)

8.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand, Malaysia, Philippines

8.8 China

8.9 Japan

8.10 South Korea

8.11 China Taiwan

8.12 India

9 Central and South America

9.1 Central and South America Sales Volume and Revenue (2020-2031)

9.2 Central and South America Key Manufacturers Sales Revenue in 2024

9.3 Central and South America Montelukast Sodium Tablet Sales and Revenue by Type (2020-2031)

9.4 Central and South America Montelukast Sodium Tablet Sales and Revenue by Application (2020-2031)

9.5 Central and South America Investment Opportunities and Key Challenges

9.6 Central and South America Montelukast Sodium Tablet Market Size by Country

9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)

9.6.2 Brazil

9.6.3 Argentina

10 Middle East and Africa

10.1 Middle East and Africa Sales Volume and Revenue (2020-2031)

10.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024

10.3 Middle East and Africa Montelukast Sodium Tablet Sales and Revenue by Type (2020-2031)

10.4 Middle East and Africa Montelukast Sodium Tablet Sales and Revenue by Application (2020-2031)

10.5 Middle East and Africa Investment Opportunities and Key Challenges

10.6 Middle East and Africa Montelukast Sodium Tablet Market Size by Country

10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)

10.6.2 GCC Countries

10.6.3 Turkey

10.6.4 Egypt

10.6.5 South Africa

11 Corporate Profile

11.1 Shanghai Anbisheng Pharmaceutical Technology Co. Ltd

11.1.1 Shanghai Anbisheng Pharmaceutical Technology Co. Ltd Corporation Information

11.1.2 Shanghai Anbisheng Pharmaceutical Technology Co. Ltd Business Overview

11.1.3 Shanghai Anbisheng Pharmaceutical Technology Co. Ltd Montelukast Sodium Tablet Product Models, Descriptions and Specifications

11.1.4 Shanghai Anbisheng Pharmaceutical Technology Co. Ltd Montelukast Sodium Tablet Sales, Price, Revenue and Gross Margin (2020-2025)

11.1.5 Shanghai Anbisheng Pharmaceutical Technology Co. Ltd Montelukast Sodium Tablet Sales by Product in 2024

11.1.6 Shanghai Anbisheng Pharmaceutical Technology Co. Ltd Montelukast Sodium Tablet Sales by Application in 2024

11.1.7 Shanghai Anbisheng Pharmaceutical Technology Co. Ltd Montelukast Sodium Tablet Sales by Geographic Area in 2024

11.1.8 Shanghai Anbisheng Pharmaceutical Technology Co. Ltd Montelukast Sodium Tablet SWOT Analysis

11.1.9 Shanghai Anbisheng Pharmaceutical Technology Co. Ltd Recent Developments

11.2 Jiangsu Vanguard Pharmaceutical Co.,Ltd.

11.2.1 Jiangsu Vanguard Pharmaceutical Co.,Ltd. Corporation Information

11.2.2 Jiangsu Vanguard Pharmaceutical Co.,Ltd. Business Overview

11.2.3 Jiangsu Vanguard Pharmaceutical Co.,Ltd. Montelukast Sodium Tablet Product Models, Descriptions and Specifications

11.2.4 Jiangsu Vanguard Pharmaceutical Co.,Ltd. Montelukast Sodium Tablet Sales, Price, Revenue and Gross Margin (2020-2025)

11.2.5 Jiangsu Vanguard Pharmaceutical Co.,Ltd. Montelukast Sodium Tablet Sales by Product in 2024

11.2.6 Jiangsu Vanguard Pharmaceutical Co.,Ltd. Montelukast Sodium Tablet Sales by Application in 2024

11.2.7 Jiangsu Vanguard Pharmaceutical Co.,Ltd. Montelukast Sodium Tablet Sales by Geographic Area in 2024

11.2.8 Jiangsu Vanguard Pharmaceutical Co.,Ltd. Montelukast Sodium Tablet SWOT Analysis

11.2.9 Jiangsu Vanguard Pharmaceutical Co.,Ltd. Recent Developments

11.3 Lunan Better Pharmaceutical Co.,Ltd

11.3.1 Lunan Better Pharmaceutical Co.,Ltd Corporation Information

11.3.2 Lunan Better Pharmaceutical Co.,Ltd Business Overview

11.3.3 Lunan Better Pharmaceutical Co.,Ltd Montelukast Sodium Tablet Product Models, Descriptions and Specifications

11.3.4 Lunan Better Pharmaceutical Co.,Ltd Montelukast Sodium Tablet Sales, Price, Revenue and Gross Margin (2020-2025)

11.3.5 Lunan Better Pharmaceutical Co.,Ltd Montelukast Sodium Tablet Sales by Product in 2024

11.3.6 Lunan Better Pharmaceutical Co.,Ltd Montelukast Sodium Tablet Sales by Application in 2024

11.3.7 Lunan Better Pharmaceutical Co.,Ltd Montelukast Sodium Tablet Sales by Geographic Area in 2024

11.3.8 Lunan Better Pharmaceutical Co.,Ltd Montelukast Sodium Tablet SWOT Analysis

11.3.9 Lunan Better Pharmaceutical Co.,Ltd Recent Developments

11.4 Otsuka

11.4.1 Otsuka Corporation Information

11.4.2 Otsuka Business Overview

11.4.3 Otsuka Montelukast Sodium Tablet Product Models, Descriptions and Specifications

11.4.4 Otsuka Montelukast Sodium Tablet Sales, Price, Revenue and Gross Margin (2020-2025)

11.4.5 Otsuka Montelukast Sodium Tablet Sales by Product in 2024

11.4.6 Otsuka Montelukast Sodium Tablet Sales by Application in 2024

11.4.7 Otsuka Montelukast Sodium Tablet Sales by Geographic Area in 2024

11.4.8 Otsuka Montelukast Sodium Tablet SWOT Analysis

11.4.9 Otsuka Recent Developments

11.5 Organon Pharma (UK) Limited

11.5.1 Organon Pharma (UK) Limited Corporation Information

11.5.2 Organon Pharma (UK) Limited Business Overview

11.5.3 Organon Pharma (UK) Limited Montelukast Sodium Tablet Product Models, Descriptions and Specifications

11.5.4 Organon Pharma (UK) Limited Montelukast Sodium Tablet Sales, Price, Revenue and Gross Margin (2020-2025)

11.5.5 Organon Pharma (UK) Limited Montelukast Sodium Tablet Sales by Product in 2024

11.5.6 Organon Pharma (UK) Limited Montelukast Sodium Tablet Sales by Application in 2024

11.5.7 Organon Pharma (UK) Limited Montelukast Sodium Tablet Sales by Geographic Area in 2024

11.5.8 Organon Pharma (UK) Limited Montelukast Sodium Tablet SWOT Analysis

11.5.9 Organon Pharma (UK) Limited Recent Developments

11.6 Taiwan Biotech Co., Ltd

11.6.1 Taiwan Biotech Co., Ltd Corporation Information

11.6.2 Taiwan Biotech Co., Ltd Business Overview

11.6.3 Taiwan Biotech Co., Ltd Montelukast Sodium Tablet Product Models, Descriptions and Specifications

11.6.4 Taiwan Biotech Co., Ltd Montelukast Sodium Tablet Sales, Price, Revenue and Gross Margin (2020-2025)

11.6.5 Taiwan Biotech Co., Ltd Recent Developments

11.7 Sandoz Private Limited

11.7.1 Sandoz Private Limited Corporation Information

11.7.2 Sandoz Private Limited Business Overview

11.7.3 Sandoz Private Limited Montelukast Sodium Tablet Product Models, Descriptions and Specifications

11.7.4 Sandoz Private Limited Montelukast Sodium Tablet Sales, Price, Revenue and Gross Margin (2020-2025)

11.7.5 Sandoz Private Limited Recent Developments

11.8 N.V. Organon

11.8.1 N.V. Organon Corporation Information

11.8.2 N.V. Organon Business Overview

11.8.3 N.V. Organon Montelukast Sodium Tablet Product Models, Descriptions and Specifications

11.8.4 N.V. Organon Montelukast Sodium Tablet Sales, Price, Revenue and Gross Margin (2020-2025)

11.8.5 N.V. Organon Recent Developments

12 Value Chain and Supply-Chain Analysis

12.1 Montelukast Sodium Tablet Industry Chain

12.2 Montelukast Sodium Tablet Upstream Materials Analysis

12.2.1 Raw Materials

12.2.2 Key Suppliers Market Share & Risk Assessment

12.3 Montelukast Sodium Tablet Integrated Production Analysis

12.3.1 Manufacturing Footprint Analysis

12.3.2 Regional Production Market Share (2020-2031)

12.3.3 Regulatory and Trade Policy Impact on Production

12.3.4 Production Technology Overview

12.3.5 Regional Cost Drivers

12.4 Montelukast Sodium Tablet Sales Channels and Distribution Networks

12.4.1 Sales Channels

12.4.2 Distributors

13 Montelukast Sodium Tablet Market Dynamics

13.1 Industry Trends and Evolution

13.2 Market Growth Drivers and Emerging Opportunities

13.3 Market Challenges, Risks, and Restraints

14 Key Findings in the Global Montelukast Sodium Tablet Study

15 Appendix

15.1 Research Methodology

15.1.1 Methodology/Research Approach

15.1.1.1 Research Programs/Design

15.1.1.2 Market Size Estimation

15.1.1.3 Market Breakdown and Data Triangulation

15.1.2 Data Source

15.1.2.1 Secondary Sources

15.1.2.2 Primary Sources

15.2 Author Details

FEATURED COMPANIES

Shanghai Anbisheng Pharmaceutical Technology Co. Ltd

Jiangsu Vanguard Pharmaceutical Co.,Ltd.

Lunan BETTER Pharmaceutical Co., Ltd.

Otsuka

TAIWAN BIOTECH CO LTD

N.V.Organon

Organon Pharma (UK) Limited

Sandoz Private Limited

List of Tables

Table 1. Global Montelukast Sodium Tablet Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)

Table 2. Global Montelukast Sodium Tablet Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)

Table 3. Global Montelukast Sodium Tablet Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 4. Global Montelukast Sodium Tablet Revenue by Region (2020-2025) & (US$ Million)

Table 5. Global Montelukast Sodium Tablet Revenue by Region (2026-2031) & (US$ Million)

Table 6. Global Montelukast Sodium Tablet Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (K Units)

Table 7. Global Montelukast Sodium Tablet Sales by Region (2020-2025) & (K Units)

Table 8. Global Montelukast Sodium Tablet Sales by Region (2026-2031) & (K Units)

Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)

Table 10. Global Montelukast Sodium Tablet Sales by Manufacturers (2020-2025) & (K Units)

Table 11. Global Montelukast Sodium Tablet Sales Share by Manufacturers (2020-2025)

Table 12. Global Montelukast Sodium Tablet Revenue by Manufacturers (2020-2025) & (US$ Million)

Table 13. Global Montelukast Sodium Tablet Revenue Market Share by Manufacturers (2020-2025)

Table 14. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)

Table 15. Global Montelukast Sodium Tablet by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Montelukast Sodium Tablet as of 2024)

Table 16. Global Montelukast Sodium Tablet Average Gross Margin (%) by Manufacturer (2020 VS 2024)

Table 17. Global Montelukast Sodium Tablet Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/Unit)

Table 18. Key Manufacturers Montelukast Sodium Tablet Manufacturing Base and Headquarters

Table 19. Global Montelukast Sodium Tablet Market Concentration Ratio (CR5 and HHI)

Table 20. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis

Table 21. Key Mergers & Acquisitions, Expansion Plans, R&D Investment

Table 22. Global Montelukast Sodium Tablet Sales by Type (2020-2025) & (K Units)

Table 23. Global Montelukast Sodium Tablet Sales by Type (2026-2031) & (K Units)

Table 24. Global Montelukast Sodium Tablet Revenue by Type (2020-2025) & (US$ Million)

Table 25. Global Montelukast Sodium Tablet Revenue by Type (2026-2031) & (US$ Million)

Table 26. Global Montelukast Sodium Tablet ASP by Type (2020-2031) & (US$/Unit)

Table 27. Technical Specifications by Key Product Type

Table 28. Global Montelukast Sodium Tablet Sales by Application (2020-2025) & (K Units)

Table 29. Global Montelukast Sodium Tablet Sales by Application (2026-2031) & (K Units)

Table 30. Montelukast Sodium Tablet High-Growth Sectors Demand CAGR (2024-2031)

Table 31. Global Montelukast Sodium Tablet Revenue by Application (2020-2025) & (US$ Million)

Table 32. Global Montelukast Sodium Tablet Revenue by Application (2026-2031) & (US$ Million)

Table 33. Global Montelukast Sodium Tablet ASP by Application (2020-2031) & (US$/Unit)

Table 34. Top Customers by Region

Table 35. Top Customers by Application

Table 36. North America Montelukast Sodium Tablet Growth Accelerators and Market Barriers

Table 37. North America Montelukast Sodium Tablet Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)

Table 38. North America Montelukast Sodium Tablet Sales (K Units) by Country (2020 VS 2024 VS 2031)

Table 39. Europe Montelukast Sodium Tablet Growth Accelerators and Market Barriers

Table 40. Europe Montelukast Sodium Tablet Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 41. Europe Montelukast Sodium Tablet Sales (K Units) by Country (2020 VS 2024 VS 2031)

Table 42. Asia-Pacific Montelukast Sodium Tablet Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 43. Asia-Pacific Montelukast Sodium Tablet Sales (K Units) by Country (2020 VS 2024 VS 2031)

Table 44. Asia-Pacific Montelukast Sodium Tablet Growth Accelerators and Market Barriers

Table 45. Southeast Asia Montelukast Sodium Tablet Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 46. Central and South America Montelukast Sodium Tablet Investment Opportunities and Key Challenges

Table 47. Central and South America Montelukast Sodium Tablet Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)

Table 48. Middle East and Africa Montelukast Sodium Tablet Investment Opportunities and Key Challenges

Table 49. Middle East and Africa Montelukast Sodium Tablet Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)

Table 50. Shanghai Anbisheng Pharmaceutical Technology Co. Ltd Corporation Information

Table 51. Shanghai Anbisheng Pharmaceutical Technology Co. Ltd Description and Major Businesses

Table 52. Shanghai Anbisheng Pharmaceutical Technology Co. Ltd Product Models, Descriptions and Specifications

Table 53. Shanghai Anbisheng Pharmaceutical Technology Co. Ltd Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 54. Shanghai Anbisheng Pharmaceutical Technology Co. Ltd Sales Value Proportion by Product in 2024

Table 55. Shanghai Anbisheng Pharmaceutical Technology Co. Ltd Sales Value Proportion by Application in 2024

Table 56. Shanghai Anbisheng Pharmaceutical Technology Co. Ltd Sales Value Proportion by Geographic Area in 2024

Table 57. Shanghai Anbisheng Pharmaceutical Technology Co. Ltd Montelukast Sodium Tablet SWOT Analysis

Table 58. Shanghai Anbisheng Pharmaceutical Technology Co. Ltd Recent Developments

Table 59. Jiangsu Vanguard Pharmaceutical Co.,Ltd. Corporation Information

Table 60. Jiangsu Vanguard Pharmaceutical Co.,Ltd. Description and Major Businesses

Table 61. Jiangsu Vanguard Pharmaceutical Co.,Ltd. Product Models, Descriptions and Specifications

Table 62. Jiangsu Vanguard Pharmaceutical Co.,Ltd. Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 63. Jiangsu Vanguard Pharmaceutical Co.,Ltd. Sales Value Proportion by Product in 2024

Table 64. Jiangsu Vanguard Pharmaceutical Co.,Ltd. Sales Value Proportion by Application in 2024

Table 65. Jiangsu Vanguard Pharmaceutical Co.,Ltd. Sales Value Proportion by Geographic Area in 2024

Table 66. Jiangsu Vanguard Pharmaceutical Co.,Ltd. Montelukast Sodium Tablet SWOT Analysis

Table 67. Jiangsu Vanguard Pharmaceutical Co.,Ltd. Recent Developments

Table 68. Lunan Better Pharmaceutical Co.,Ltd Corporation Information

Table 69. Lunan Better Pharmaceutical Co.,Ltd Description and Major Businesses

Table 70. Lunan Better Pharmaceutical Co.,Ltd Product Models, Descriptions and Specifications

Table 71. Lunan Better Pharmaceutical Co.,Ltd Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 72. Lunan Better Pharmaceutical Co.,Ltd Sales Value Proportion by Product in 2024

Table 73. Lunan Better Pharmaceutical Co.,Ltd Sales Value Proportion by Application in 2024

Table 74. Lunan Better Pharmaceutical Co.,Ltd Sales Value Proportion by Geographic Area in 2024

Table 75. Lunan Better Pharmaceutical Co.,Ltd Montelukast Sodium Tablet SWOT Analysis

Table 76. Lunan Better Pharmaceutical Co.,Ltd Recent Developments

Table 77. Otsuka Corporation Information

Table 78. Otsuka Description and Major Businesses

Table 79. Otsuka Product Models, Descriptions and Specifications

Table 80. Otsuka Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 81. Otsuka Sales Value Proportion by Product in 2024

Table 82. Otsuka Sales Value Proportion by Application in 2024

Table 83. Otsuka Sales Value Proportion by Geographic Area in 2024

Table 84. Otsuka Montelukast Sodium Tablet SWOT Analysis

Table 85. Otsuka Recent Developments

Table 86. Organon Pharma (UK) Limited Corporation Information

Table 87. Organon Pharma (UK) Limited Description and Major Businesses

Table 88. Organon Pharma (UK) Limited Product Models, Descriptions and Specifications

Table 89. Organon Pharma (UK) Limited Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 90. Organon Pharma (UK) Limited Sales Value Proportion by Product in 2024

Table 91. Organon Pharma (UK) Limited Sales Value Proportion by Application in 2024

Table 92. Organon Pharma (UK) Limited Sales Value Proportion by Geographic Area in 2024

Table 93. Organon Pharma (UK) Limited Montelukast Sodium Tablet SWOT Analysis

Table 94. Organon Pharma (UK) Limited Recent Developments

Table 95. Taiwan Biotech Co., Ltd Corporation Information

Table 96. Taiwan Biotech Co., Ltd Description and Major Businesses

Table 97. Taiwan Biotech Co., Ltd Product Models, Descriptions and Specifications

Table 98. Taiwan Biotech Co., Ltd Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 99. Taiwan Biotech Co., Ltd Recent Developments

Table 100. Sandoz Private Limited Corporation Information

Table 101. Sandoz Private Limited Description and Major Businesses

Table 102. Sandoz Private Limited Product Models, Descriptions and Specifications

Table 103. Sandoz Private Limited Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 104. Sandoz Private Limited Recent Developments

Table 105. N.V. Organon Corporation Information

Table 106. N.V. Organon Description and Major Businesses

Table 107. N.V. Organon Product Models, Descriptions and Specifications

Table 108. N.V. Organon Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 109. N.V. Organon Recent Developments

Table 110. Key Raw Materials Distribution

Table 111. Raw Materials Key Suppliers

Table 112. Critical Raw Material Supplier Concentration (2024) & Risk Index

Table 113. Milestones in Production Technology Evolution

Table 114. Distributors List

Table 115. Market Trends and Market Evolution

Table 116. Market Drivers and Opportunities

Table 117. Market Challenges, Risks, and Restraints

Table 118. Research Programs/Design for This Report

Table 119. Key Data Information from Secondary Sources

Table 120. Key Data Information from Primary Sources

List of Figures

Figure 1. Montelukast Sodium Tablet Product Picture

Figure 2. Global Montelukast Sodium Tablet Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)

Figure 3. Original Drug Product Picture

Figure 4. Generic Drug Product Picture

Figure 5. Global Montelukast Sodium Tablet Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)

Figure 6. Hospital

Figure 7. Pharmacy

Figure 8. Others

Figure 9. Montelukast Sodium Tablet Report Years Considered

Figure 10. Global Montelukast Sodium Tablet Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 11. Global Montelukast Sodium Tablet Revenue (2020-2031) & (US$ Million)

Figure 12. Global Montelukast Sodium Tablet Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)

Figure 13. Global Montelukast Sodium Tablet Revenue Market Share by Region (2020-2031)

Figure 14. Global Montelukast Sodium Tablet Sales (2020-2031) & (K Units)

Figure 15. Global Montelukast Sodium Tablet Sales (CAGR) by Region (2020-2031) (K Units)

Figure 16. Global Montelukast Sodium Tablet Sales Market Share by Region (2020-2031)

Figure 17. Top 5 and Top 10 Manufacturers Montelukast Sodium Tablet Sales Volume Market Share in 2024

Figure 18. Global Montelukast Sodium Tablet Revenue Market Share Ranking (2024)

Figure 19. Tier Distribution by Revenue Contribution (2020 VS 2024)

Figure 20. Original Drug Revenue Market Share by Manufacturer in 2024

Figure 21. Generic Drug Revenue Market Share by Manufacturer in 2024

Figure 22. Global Montelukast Sodium Tablet Sales Market Share by Type (2020-2031)

Figure 23. Global Montelukast Sodium Tablet Revenue Market Share by Type (2020-2031)

Figure 24. Global Montelukast Sodium Tablet Sales Market Share by Application (2020-2031)

Figure 25. Global Montelukast Sodium Tablet Revenue Market Share by Application (2020-2031)

Figure 26. North America Montelukast Sodium Tablet Sales YoY (2020-2031) & (K Units)

Figure 27. North America Montelukast Sodium Tablet Revenue YoY (2020-2031) & (US$ Million)

Figure 28. North America Top 5 Manufacturers Montelukast Sodium Tablet Sales Revenue (US$ Million) in 2024

Figure 29. North America Montelukast Sodium Tablet Sales Volume (K Units) by Type (2020- 2031)

Figure 30. North America Montelukast Sodium Tablet Sales Revenue (US$ Million) by Type (2020 - 2031)

Figure 31. North America Montelukast Sodium Tablet Sales Volume (K Units) by Application (2020-2031)

Figure 32. North America Montelukast Sodium Tablet Sales Revenue (US$ Million) by Application (2020-2031)

Figure 33. US Montelukast Sodium Tablet Revenue (2020-2031) & (US$ Million)

Figure 34. Canada Montelukast Sodium Tablet Revenue (2020-2031) & (US$ Million)

Figure 35. Mexico Montelukast Sodium Tablet Revenue (2020-2031) & (US$ Million)

Figure 36. Europe Montelukast Sodium Tablet Sales YoY (2020-2031) & (K Units)

Figure 37. Europe Montelukast Sodium Tablet Revenue YoY (2020-2031) & (US$ Million)

Figure 38. Europe Top 5 Manufacturers Montelukast Sodium Tablet Sales Revenue (US$ Million) in 2024

Figure 39. Europe Montelukast Sodium Tablet Sales Volume (K Units) by Type (2020-2031)

Figure 40. Europe Montelukast Sodium Tablet Sales Revenue (US$ Million) by Type (2020-2031)

Figure 41. Europe Montelukast Sodium Tablet Sales Volume (K Units) by Application (2020-2031)

Figure 42. Europe Montelukast Sodium Tablet Sales Revenue (US$ Million) by Application (2020-2031)

Figure 43. Germany Montelukast Sodium Tablet Revenue (2020-2031) & (US$ Million)

Figure 44. France Montelukast Sodium Tablet Revenue (2020-2031) & (US$ Million)

Figure 45. U.K. Montelukast Sodium Tablet Revenue (2020-2031) & (US$ Million)

Figure 46. Italy Montelukast Sodium Tablet Revenue (2020-2031) & (US$ Million)

Figure 47. Russia Montelukast Sodium Tablet Revenue (2020-2031) & (US$ Million)

Figure 48. Asia-Pacific Montelukast Sodium Tablet Sales YoY (2020-2031) & (K Units)

Figure 49. Asia-Pacific Montelukast Sodium Tablet Revenue YoY (2020-2031) & (US$ Million)

Figure 50. Asia-Pacific Top 8 Manufacturers Montelukast Sodium Tablet Sales Revenue (US$ Million) in 2024

Figure 51. Asia-Pacific Montelukast Sodium Tablet Sales Volume (K Units) by Type (2020- 2031)

Figure 52. Asia-Pacific Montelukast Sodium Tablet Sales Revenue (US$ Million) by Type (2020- 2031)

Figure 53. Asia-Pacific Montelukast Sodium Tablet Sales Volume (K Units) by Application (2020-2031)

Figure 54. Asia-Pacific Montelukast Sodium Tablet Sales Revenue (US$ Million) by Application (2020-2031)

Figure 55. Indonesia Montelukast Sodium Tablet Revenue (2020-2031) & (US$ Million)

Figure 56. Japan Montelukast Sodium Tablet Revenue (2020-2031) & (US$ Million)

Figure 57. South Korea Montelukast Sodium Tablet Revenue (2020-2031) & (US$ Million)

Figure 58. China Taiwan Montelukast Sodium Tablet Revenue (2020-2031) & (US$ Million)

Figure 59. India Montelukast Sodium Tablet Revenue (2020-2031) & (US$ Million)

Figure 60. Central and South America Montelukast Sodium Tablet Sales YoY (2020-2031) & (K Units)

Figure 61. Central and South America Montelukast Sodium Tablet Revenue YoY (2020-2031) & (US$ Million)

Figure 62. Central and South America Top 5 Manufacturers Montelukast Sodium Tablet Sales Revenue (US$ Million) in 2024

Figure 63. Central and South America Montelukast Sodium Tablet Sales Volume (K Units) by Type (2021-2031)

Figure 64. Central and South America Montelukast Sodium Tablet Sales Revenue (US$ Million) by Type (2020-2031)

Figure 65. Central and South America Montelukast Sodium Tablet Sales Volume (K Units) by Application (2020-2031)

Figure 66. Central and South America Montelukast Sodium Tablet Sales Revenue (US$ Million) by Application (2020-2031)

Figure 67. Brazil Montelukast Sodium Tablet Revenue (2020-2025) & (US$ Million)

Figure 68. Argentina Montelukast Sodium Tablet Revenue (2020-2025) & (US$ Million)

Figure 69. Middle East, and Africa Montelukast Sodium Tablet Sales YoY (2020-2031) & (K Units)

Figure 70. Middle East and Africa Montelukast Sodium Tablet Revenue YoY (2020-2031) & (US$ Million)

Figure 71. Middle East and Africa Top 5 Manufacturers Montelukast Sodium Tablet Sales Revenue (US$ Million) in 2024

Figure 72. Middle East and Africa Montelukast Sodium Tablet Sales Volume (K Units) by Type (2021-2031)

Figure 73. South America Montelukast Sodium Tablet Sales Revenue (US$ Million) by Type (2020-2031)

Figure 74. Middle East and Africa Montelukast Sodium Tablet Sales Volume (K Units) by Application (2020-2031)

Figure 75. Middle East and Africa Montelukast Sodium Tablet Sales Revenue (US$ Million) by Application (2020-2031)

Figure 76. GCC Countries Montelukast Sodium Tablet Revenue (2020-2025) & (US$ Million)

Figure 77. Turkey Montelukast Sodium Tablet Revenue (2020-2025) & (US$ Million)

Figure 78. Egypt Montelukast Sodium Tablet Revenue (2020-2025) & (US$ Million)

Figure 79. South Africa Montelukast Sodium Tablet Revenue (2020-2025) & (US$ Million)

Figure 80. Montelukast Sodium Tablet Industry Chain Mapping

Figure 81. Regional Montelukast Sodium Tablet Manufacturing Base Distribution (%)

Figure 82. Global Montelukast Sodium Tablet Production Market Share by Region (2020-2031)

Figure 83. Montelukast Sodium Tablet Production Process

Figure 84. Regional Montelukast Sodium Tablet Production Cost Structure

Figure 85. Channels of Distribution (Direct Vs Distribution)

Figure 86. Bottom-up and Top-down Approaches for This Report

Figure 87. Data Triangulation

Figure 88. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions